Bonerge at Expo West 2026: From Lifespan to Healthspan

Anaheim, California —As the 45th Natural Products Expo West 2026 concludes, the global nutraceutical industry is reflecting on a pivotal shift in health innovation. This year’s discussions moved beyond traditional recovery concepts toward a new focus on precision and integration.

At Expo West 2026, Bonerge showcased its flagship innovative ingredients—BeFisetin®, EquoYouth™, StanYouth®, and Amuctive™ AKK—while engaging with global brand owners, formulators, and distributors to explore the next generation of longevity and precision nutrition solutions.

Against the backdrop of GLP-1 medications reshaping weight management and longevity science becoming increasingly accessible, the dietary supplement sector is undergoing a structural transformation. Several major industry trends emerged during the event.

The GLP-1 Era: Reshaping the Logic of Weight Management

The rapid adoption of GLP-1 receptor agonists has evolved from a temporary market trend into a structural shift across the health and nutrition industry.

Many leading ingredient companies at Expo West reached a similar conclusion: the rise of weight-loss medications is creating a new category—“GLP-1 Companion Nutrition.”

While GLP-1 therapies effectively reduce body weight by suppressing appetite and slowing gastric emptying, users often face challenges such as:

• loss of lean muscle mass

• insufficient nutrient intake

• micronutrient deficiencies

In response, new nutritional strategies are emerging, including nutrient-dense, high-protein, and low-sugar functional foods. The market is gradually shifting from traditional meal replacement solutions toward precision nutrition designed to complement medication-driven weight management.

Bonerge’s Strategic Response

To address these emerging needs, Bonerge introduced Amuctive™ AKK, an innovative ingredient designed to support metabolic balance in GLP-1 users, particularly during the post-medication phase when weight rebound becomes a key concern.

Maximizing "Healthspan": The Integration of Functionality and Eastern Wisdom

Across the exhibition floor, one theme repeatedly surfaced: the shift from simply extending Lifespan to improving Healthspan—the number of years people live in good health.

Industry experts increasingly highlight the “last-decade health gap,” where many individuals experience declining health toward the end of life. Nutritional innovation is now focusing on reducing this gap through targeted functional ingredients.

The Democratization of Longevity Science

Concepts such as cellular energy metabolism and mitochondrial health are no longer limited to specialized anti-aging research. Instead, they are being repositioned as daily nutritional strategies for the mainstream 40–60 age group.

For Generation X and Baby Boomers, longevity support is evolving from a niche luxury into a practical lifestyle requirement.

New Scientific Anchors for Traditional Botanicals

At the same time, traditional botanical ingredients are gaining renewed attention in Western markets. Adaptogenic plants and bioactive compounds are re-entering the global conversation with a stronger emphasis on evidence-based validation and sustainable cultivation practices.

Bonerge’s Holistic Innovation

Bonerge’s core portfolio—including BeFisetin® Fisetin and EquoYouth™ S-Equol—addresses targeted needs in cellular anti-aging and female health.

A notable example is StanYouth® CR3, Bonerge’s compound longevity solution. Built upon the “Senolytic–Repair–Chi” Theory for Cellular Renewal, it integrates modern senolytic science with the traditional Chinese medicine concept of Chi (vital energy), forming a comprehensive Cleanse–Repair–Vitalize framework.

Micro-ecosystem Evolution: Postbiotics and Mucosal Immunity

Another key trend at Expo West was the rapid evolution of gut microbiome innovation.

The market is gradually shifting from traditional probiotics toward postbiotics, which offer greater stability, safety, and formulation flexibility.

At the same time, the scientific focus is expanding beyond simple microbiota balance to gut barrier integrity, reflecting growing consumer awareness around digestive resilience, mucosal immunity, and food sensitivities.

Bonerge’s Technical Edge:

Bonerge’s Amuctive™ AKK leverages heat-inactivated technology while retaining high levels of the active protein Amuc_1100.

This provides a scientifically validated pathway for repairing the intestinal barrier and supporting systemic metabolic health through various "gut-organ axes."

Cross-Boundary Innovation: From "Anti-Wrinkle" to Cellular Homeostasis

The traditional boundary between beauty and health continues to blur.

A new generation of ingestible beauty products is moving beyond simple “anti-wrinkle” positioning toward deeper biological functions such as cellular repair and homeostasis regulation.

At the ingredient level, clean label principles and supply chain transparency are increasingly becoming baseline expectations for global brands.

Bonerge’s Dual-Application Synergy:

Both BeFisetin® Fisetin and StanYouth® Urolithin A have obtained New Cosmetic Ingredient registration in China, enabling dual-application opportunities across nutritional supplements and topical skincare formulations.

This dual-track capability allows brands to develop genuine “Inside-Out Beauty” strategies, using the same scientifically validated ingredients to support both internal nutrition and external skin health.

Global Supply Chain Transformation: From "Suppliers" to "Solution Providers"

One of the most noticeable shifts at Expo West 2026 was the evolving role of ingredient manufacturers.

Leading companies are moving beyond the traditional role of raw material suppliers to become innovation partners and solution providers for global brands.

Through stronger scientific validation and differentiated technologies, companies like Bonerge are increasingly engaging directly with international brands and formulators.

Rather than simply supplying ingredients, the focus is shifting toward delivering science-backed, application-ready solutions that help partners navigate regulatory complexity and rapidly evolving market demands.

Conclusion: Nourishing the Quality of Life

Expo West 2026 signals the gradual end of the “one-size-fits-all” supplement era.

As consumers become more informed and health goals become increasingly personalized, the future of the industry lies in science-driven, integrated health solutions that genuinely support long-term quality of life.

As one of Bonerge’s global partners noted during the exhibition:

“Consumers are smarter than ever before. They are no longer looking for a universal miracle pill, but for precise solutions that can integrate into daily life and genuinely support long-term wellbeing.”

This sentiment captured one of the most important takeaways from Expo West 2026: the future of nutritional supplements lies not only in innovation, but in deeply nourishing the quality of life.

Bonerge remains committed to empowering global partners with high-value, innovative ingredients and scientifically grounded solutions—helping shape the next generation of longevity, metabolic health, and precision nutrition.